Clinical trial
Risperidone Treatment for Military Service Related Chronic Post Traumatic Stress…
NCT00099983 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00099983 |
|---|---|
| Title | Risperidone Treatment for Military Service Related Chronic Post Traumatic Stress Disorder |
| Official title | CSP #504 - Risperidone Treatment for Military Service Related Chronic Post-Traumatic Stress Disorder |
| Acronym | CSP #504 |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Janssen, LP Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Stress Disorders, Post-Traumatic |
| Intervention type | Drug |
| Interventions | Risperidone, Placebo |
| Enrollment | 296 |
| Start date | Oct 1, 2006 |
| Primary completion | Feb 1, 2010 |
| Completion | Jan 1, 2011 |
| First posted | Dec 22, 2004 |
| Last update posted | Aug 22, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: